168 related articles for article (PubMed ID: 3443824)
1. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function.
Oellerich M; Raude E; Burdelski M; Schulz M; Schmidt FW; Ringe B; Lamesch P; Pichlmayr R; Raith H; Scheruhn M
J Clin Chem Clin Biochem; 1987 Dec; 25(12):845-53. PubMed ID: 3443824
[TBL] [Abstract][Full Text] [Related]
2. Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
Huang YS; Lee SD; Deng JF; Wu JC; Lu RH; Lin YF; Wang YJ; Lo KJ
J Hepatol; 1993 Aug; 19(1):140-7. PubMed ID: 8301034
[TBL] [Abstract][Full Text] [Related]
3. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat.
Leclercq I; Saliez A; Wallemacq PE; Horsmans Y; Lambotte L
Hepatology; 1997 Nov; 26(5):1182-8. PubMed ID: 9362360
[TBL] [Abstract][Full Text] [Related]
4. Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.
Muñoz AE; Miguez C; Rubio M; Bartellini M; Levi D; Podestá A; Niselman V; Terg R
Dig Dis Sci; 1999 Apr; 44(4):789-95. PubMed ID: 10219840
[TBL] [Abstract][Full Text] [Related]
5. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
Kupcová V; Turecký L; Szántová M; Schmidtová K
Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
[TBL] [Abstract][Full Text] [Related]
6. Determination of monoethylglycinexylidide by fluorescence polarization immunoassay in highly icteric serum samples: modified precipitation procedure and HPLC compared.
Schütz E; Shipkova M; Niedmann PD; Wieland E; Armstrong VW; Oellerich M
Clin Chem; 1998 Jun; 44(6 Pt 1):1269-74. PubMed ID: 9625052
[TBL] [Abstract][Full Text] [Related]
7. Assessment of lidocaine metabolite formation as a quantitative liver function test in children.
Gremse DA; A-Kader HH; Schroeder TJ; Balistreri WF
Hepatology; 1990 Sep; 12(3 Pt 1):565-9. PubMed ID: 2401461
[TBL] [Abstract][Full Text] [Related]
8. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.
Oellerich M; Burdelski M; Lautz HU; Schulz M; Schmidt FW; Herrmann H
Ther Drug Monit; 1990 May; 12(3):219-26. PubMed ID: 2349604
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence polarization immunoassay and HPLC assays compared for measuring monoethylglycinexylidide in liver-transplant patients.
Chen Y; Potter JM
Clin Chem; 1992 Dec; 38(12):2426-30. PubMed ID: 1458579
[TBL] [Abstract][Full Text] [Related]
10. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
Zotz RB; von Schönfeld J; Erhard J; Breuer N; Lange R; Beste M; Goebell H; Eigler FW
Transplantation; 1997 Feb; 63(4):538-41. PubMed ID: 9047147
[TBL] [Abstract][Full Text] [Related]
11. Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis.
Bhise SB; Dias RJ
Indian J Gastroenterol; 2007; 26(4):167-9. PubMed ID: 17986743
[TBL] [Abstract][Full Text] [Related]
12. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
[TBL] [Abstract][Full Text] [Related]
13. Capillary gas chromatographic method for the measurement of small concentrations of monoethylglycinexylidide and lidocaine in plasma.
Laroche N; Leneveu A; Roux A; Flouvat B
J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):375-81. PubMed ID: 9824255
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of lidocaine metabolite (monoethylglycinexylidide) as a liver function test].
Shimanuki K; Suzuki W; Sakurabayashi I; Kiyozaki H; Shinohara K; Soda K; Kai T; Satake M; Miyata M
Nihon Shokakibyo Gakkai Zasshi; 1993 Jan; 90(1):33-40. PubMed ID: 8433534
[TBL] [Abstract][Full Text] [Related]
15. Reassessment of monoethylglycinexylidide as preoperative liver function test in a rat model of liver cirrhosis and man.
Kaneko H; Otsuka Y; Katagiri M; Maeda T; Tsuchiya M; Tamura A; Ishii T; Takagi S; Shiba T
Clin Exp Med; 2001 Mar; 1(1):19-26. PubMed ID: 11467398
[TBL] [Abstract][Full Text] [Related]
16. Lidocaine elimination and monoethylglycinexylidide formation in the dehydrated camel.
Ben-Zvi Z; Goldin G; Van Creveld C; Yagil R
J Vet Pharmacol Ther; 1995 Dec; 18(6):442-5. PubMed ID: 8789697
[TBL] [Abstract][Full Text] [Related]
17. Comparison of MEGX (monoethylglycinexylidide) and antipyrine tests in patients with liver cirrhosis.
Wojcicki J; Kozlowski K; Drozdzik M; Wojcicki M
Eur J Drug Metab Pharmacokinet; 2002; 27(4):243-7. PubMed ID: 12587953
[TBL] [Abstract][Full Text] [Related]
18. Formation of monoethylglycinexylidide (MEGX) in clinically healthy dogs.
Neumann S; Frenz M; Streit F; Oellerich M
Can J Vet Res; 2011 Oct; 75(4):317-20. PubMed ID: 22468031
[TBL] [Abstract][Full Text] [Related]
19. The MEGX test: a tool for the real-time assessment of hepatic function.
Oellerich M; Armstrong VW
Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522
[TBL] [Abstract][Full Text] [Related]
20. Assessment of monoethylglycinexylidide as measure of liver function for patients with chronic viral hepatitis.
Elin RJ; Fried MW; Sampson M; Ruddel M; Kleiner DE; DiBisceglie AM
Clin Chem; 1997 Oct; 43(10):1952-7. PubMed ID: 9342018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
